![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 2, 1426-1432, January 11, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the
Received for publication, August 17, 2001, and in revised form, October 24, 2001
White adipose tissue mass is governed by
competing processes that control lipid synthesis and storage, the
development of new adipocytes, and their survival. We have shown that
the transcription factor cAMP-response element-binding protein (CREB)
participates in adipogenesis, with constitutively active forms of CREB
inducing adipocyte differentiation and dominant negative forms of CREB blocking this process. In other cell types, CREB and related factors have been shown to play important roles in survival and apoptosis. Here
we demonstrate that reduction of CREB activity by ectopic expression of
the dominant negative CREB, KCREB, induces apoptosis of mature 3T3-L1
adipocytes in culture. Death by apoptosis was confirmed by increased
nuclear condensation, changes in membrane morphology, and increased DNA
fragmentation. Gene microarray analysis indicated that KCREB expression
increased expression of several pro-apoptotic genes like Interleukin
Converting Enzyme and decreased the expression of the anti-apoptotic
signaling molecule, Akt/protein kinase B. Finally, introduction of
constitutively active CREB, CREB-DIEDML, blocked death of mature
adipocytes treated with TNF- In addition to its primary role in energy storage, white adipose
tissue plays significant roles in overall energy homeostasis and
metabolic regulation and, in part, regulates satiety and insulin sensitivity (1). Diseases or dysfunction of white adipose tissue are
observed with increasing frequency in clinical situations. For example,
overweight and obesity and related conditions, including diabetes and
cardiovascular disease, are reaching epidemic proportions worldwide
(2-4). Loss or redistribution of adipose tissue associated with
acquired or congenital lipodystrophies, or due to aggressive antiretroviral therapy or subcutaneous insulin injection, also constitutes a growing health concern (5-8). Although these syndromes reflect the action of numerous interacting processes, they all are
characterized by changes in adipose tissue mass.
Adipose tissue mass is governed in part through competing processes
that either increase or decrease the size, number, and "maturity"
of fat cells (9). Adipocyte size increases via increased storage of
triacylglycerol from dietary sources or generated by lipogenic
pathways; new fat cells may arise via the proliferation and
differentiation of pre-adipocytes or adipoblasts to mature adipocytes
(10). Alternately, decreases in adipose tissue mass generally involve
the loss of stored lipids by lipolytic processes. There is now evidence
that decreases in adipose tissue mass may also involve the loss of
mature fat cells through programmed cell death or apoptosis in certain
situations (8, 11-17).
In culture, adipocytes from rodents or cell lines like 3T3-L1 undergo
apoptosis upon exposure to
TNF- Previously, we have shown that the transcription factor CREB is a
target for extracellular agents and intracellular signaling systems
that induce adipogenesis (18, 19). Ectopic expression of a
constitutively active, chimeric VP16-CREB protein was sufficient to
induce adipogenesis, whereas expression of a dominant negative form of
CREB, KCREB, blocked the adipogenic program. Similar roles for CREB
have been observed in neuronal cells where it participates in
differentiation and neurite outgrowth (20-22). CREB also serves as a
potent survival factor in neurons preventing apoptosis due to
neurotrophin withdrawal (23-26). When KCREB is expressed in mature
adipocytes, we observe a loss of triacylglycerol vesicles and cells
with typical adipocyte morphology over a 4- to 8-day period. Is this
loss due to lipolysis and dedifferentiation of fat cells or is it due
to adipocyte apoptosis? Here we show that ectopic expression of KCREB
leads to apoptosis of mature adipocytes, which are replaced by
undifferentiated pre-adipocytes in culture. Apoptosis was concomitant
with an increase in several pro-apoptotic genes and down-regulation of
the anti-apoptotic protein kinase B/Akt. We also demonstrate that
ectopic expression of constitutively active forms of CREB block
adipocyte apoptosis in response to exposure to TNF- Materials--
All standard chemicals were from Sigma
Chemical Co. (St. Louis, MO), and anti-Akt antibody was from Cell
Signaling (Beverly, MA). All supplies and reagents for SDS-PAGE
were from Novex/Invitrogen (Carlsbad, CA). Cell culture media and
supplies were from Invitrogen (Beverly, MA) and Gemini Bioproducts
(Gaithersburg, MD). The Ecdysone-inducible expression system
(pIND, pVgRXR vectors, zeocin, and Ponasterone A) was from
Invitrogen. The PI3K inhibitor was purchased from Calbiochem,
and the adenoviral expression vector for Akt(K179M) was provided by Dr.
Carol Sable (VA Medical Center, Denver, CO).
Cell Culture--
3T3-L1 fibroblasts were grown to confluence in
fibroblast growth medium (Dulbecco's modified Eagle's medium
containing 5.5 mM glucose, 10% fetal calf serum (FCS), and
0.5 mM glutamine). Differentiation was initiated by
addition of medium containing 10% FCS, 1 mM glutamine, 500 µM isobutylmethylxanthine (or 300 µM
Bt2cAMP), 1 µM dexamethasone, and 1 µg/ml
insulin. After 2 days, cells were transferred to adipocyte growth
medium containing 25 mM glucose, 0.5 mM
glutamine, 10% FCS, 1 mM glutamine, and 1 µg/ml insulin
and re-fed every 2 days. Differentiation of fibroblasts into mature
adipocytes was confirmed by Oil Red O staining (18).
Transfection Procedures--
Plates of 3T3-L1 fibroblasts were
grown to 70-80% confluency and transfected with the indicated
plasmids with Superfect Reagent (Qiagen, Valencia, CA) according to the
manufacturer's recommendations. Cells stably transfected with the
plasmid pVgRXR were selected in conventional medium containing 500 µg/ml zeocin, and cells stably transfected with pIND-KCREB,
pIND-VP16-CREB, pIND-CREB-DIEDML, or pIND-LacZ plasmids were selected
in medium containing 500 µg/ml Geneticin. Large, rapidly growing,
well-separated colonies were isolated 10-12 days after selection was
begun with either antibiotic. Isolated clones were passaged in low
glucose Dulbecco's modified Eagle's medium containing 10% FCS, 1 mM L-glutamine, and 500 µg/ml each of zeocin
and Geneticin. KCREB, VP16-CREB, CREB-DIEDML or LacZ expression was
induced through the addition of 5 µM Ponasterone A to the
growth medium. Assays were performed on cells growing on eight-chamber
microscope slides. Ten days following the initiation of
differentiation, the cells were stained with Oil Red O and counterstained with hematoxylin to visualize cell morphology. Cells
were observed by bright-field microscopy, and representative fields
were photographed with Kodak 200 film. Alternately, cells growing on
multiwell slides were lysed directly in Laemmli SDS gel loading buffer,
and the lysates were subjected to Western blot analysis for marker
protein expression.
Ecdysone-inducible Expression System--
The Ecdysone-inducible
expression system was employed to prepare stably transfected
3T3-L1cells in which we could induce the expression of KCREB,
CREB-DIEDML, and LacZ as described previously (18, 19).
Western Blot Analysis--
After correcting for protein
concentrations, lysates from 3T3-L1 fibroblasts and adipocytes treated
as described in the figure legends were prepared in Laemmli SDS loading
buffer, resolved on 10% polyacrylamide-SDS gels, and transferred to
nitrocellulose. The nitrocellulose blots were blocked with
phosphate-buffered saline containing 5% dry milk and 0.1% Tween 20 and then treated with antibodies that recognize Akt, CREB, or VP16. The
blots were washed and subsequently treated with goat anti-rabbit IgG
conjugated to alkaline phosphatase. After the blots were washed,
specific immune complexes for each target protein were visualized with 5-bromo-4-chloro-3-indolyl phosphate and nitro blue tetrazolium.
Analysis of Nuclear Condensation--
Nuclear condensation in
apoptotic cells was determined by microscopic observation of cells
stained with Hoechst 33342. Control cells (LacZ expressing),
KCREB-expressing cells, or cells treated with TNF- Flow Cytometry--
Essentially, 3T3-L1 cells were lifted from
culture containers by gentle trypsinization and washed twice in PBS.
The cells were resuspended in a buffer containing 100 mM
Tris-HCl, pH 7.6, and 1 mM EDTA at 4° C. Immediately, an
equal volume of 100% ethanol was added dropwise while vortexing, and
the cells were fixed for 3 h at 4° C. After fixing, an
additional volume of 100 mM Tris-HCl, pH 7.6, containing
0.1% Nonidet P-40, 20 units/ml RNase A, and 75 µM
propidium iodide was added while vortexing, and the suspension was
placed under refrigeration overnight. The following day the suspensions
were subjected to flow cytometry on a Becton Dickinson FACScan linked
to a Macintosh G3 computer running CellQuest software.
Atlas cDNA Array Analysis--
Total RNA was extracted from
cells using the Atlas Pure Total RNA Labeling kit from
CLONTECH (Palo Alto, CA). Single-strand cDNA
probes were generated from total RNA using [32P]dATP.
These probes were used for hybridization with separate Mouse
cDNA array membranes using protocols and reagents provided by the
manufacturer (CLONTECH). Arrays were subjected to
autoradiography at We have reported that CREB participates in the induction of
adipogenesis. As part of the studies, we noted that CREB
phosphorylation and activity were stimulated by conventional
differentiation-inducing agents in an acute fashion, but were also
transiently elevated at later times during adipogenesis. This suggested
that CREB might also play a role in later stages of the differentiation
process. In addition, our results in adipocyte cell lines parallel
similar results in neurons wherein CREB not only participates in
differentiation but also acts as a survival factor preventing apoptosis
in the absence of neurotrophins. These factors led us to hypothesize that CREB may also play roles in the later stages of adipocyte differentiation or in maintaining the mature adipocyte phenotype.
As an initial test of this hypothesis, we blocked the activity of
endogenous CREB in mature adipocytes through the ectopic expression of
the dominant negative CREB protein, KCREB (27). KCREB inhibits the
action of endogenous CREB by forming heterodimers with the endogenous
protein that are incapable of binding target DNA sequences. KCREB
differs from CREB by one amino acid in the DNA binding domain, and
antibodies capable of differentiating between CREB and KCREB do not
exist. However, using antibodies that recognize both proteins we were
able to detect Ponasterone A-induced KCREB expression in 3T3-L1
adipocytes by Western blot (Fig.
1A). Inhibition of endogenous
CREB activity by KCREB was verified by demonstrating that KCREB
expression blocked dibutyryl-cAMP (Bt2cAMP)-stimulated
transcription from the CRE-containing somatostatin gene
promoter (Fig. 1B). We found that within 6-9 days following the initiation of KCREB expression in mature adipocytes, no
triacylglycerol vesicles were visible in the cells, and in general, the
cells lacked the characteristic rounded morphology of adipocytes (Fig. 1C). Similar results were obtained when adipocytes were
infected with adenoviral vectors expressing other dominant negative
CREBs, including CREBm1 and ACREB (data not shown).
We initially proposed that the changes elicited by KCREB reflected
lipolysis of triacylglycerol stores and partial dedifferentiation. However, close examination of the cultures revealed a substantial number of non-adherent cells suggesting that the loss of mature adipocytes may have been due to cell death. To test the later hypothesis we expressed KCREB in mature adipocytes over several days
and looked for apoptotic nuclear condensation by Hoechst staining. As
shown in Fig. 2A, KCREB
expression produced a time-dependent, transient increase in
cells containing brightly staining nuclei indicative of nuclear
condensation. The number of cells with apoptotic nuclei reached an
apparent maximum on day 3 and then declined over the following 72 h. During the 6-day period, cells with dimly staining non-apoptotic
nuclei, fibroblast morphology, and lacking lipid vesicles increased in
number. These data suggested that KCREB expression induced the death of
mature adipocytes, which were replaced in culture by undifferentiated
pre-adipocytes. In addition to nuclear condensation, we also noted
changes in membrane morphology consistent with apoptosis,
including membrane retraction (Fig. 2B) and the
formation of "blebs" (Fig. 2C).
Inhibition of cAMP-response Element-binding Protein Activity
Decreases Protein Kinase B/Akt Expression in 3T3-L1 Adipocytes and
Induces Apoptosis*
§¶ and
**
§§
Endocrinology and
Pulmonary and
Critical Sections, and ** Research Service, Veterans Affairs
Medical Center, Denver, Colorado 80220 and the Departments of
§ Endocrinology and ¶ Medicine, and

Cardiovascular Pulmonary Research
Laboratory, University of Colorado Health Sciences Center, Denver,
Colorado 80262
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
. The data indicate that CREB plays a
central role in adipocyte survival, perhaps by regulating the
expression of certain pro- and anti-apoptotic genes. These results not
only extend the role of CREB in adipocyte biology but also highlight
the general developmental and survival role of this factor in numerous
cell and tissue types.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
1 or HIV protease
inhibitors (8, 17). Ectopic overexpression of constitutively active
MKK6, an activator of p38 MAPK, also induces apoptosis and necrosis of
3T3-L1 adipocytes (11). Other studies in rodents have demonstrated a
decrease in adipose tissue DNA content due to loss of adipocytes in
response to starvation or streptozotocin-induced diabetes (14). More
recently, intracerebroventricular administration of leptin was also
shown to decrease fat pad weight and DNA content (16). Apoptotic
features, including DNA laddering and terminal deoxynucleotidyl
transferase-mediated dUTP nick end labeling (TUNEL) staining
accompanied these changes. Apoptosis of adipose tissue cells has also
been observed in human adipose tissue explants subjected to growth
factor deprivation, elevated temperature, or TNF-
exposure as
determined by changes in cell morphology and DNA laddering (12, 15).
Similar results were reported for adipose tissue explants retrieved
from cancer patients (13).
. These results
indicate that CREB acts as a survival factor in mature
adipocytes and may play out a role in regulating adipose tissue mass
and controlling insulin sensitivity.
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
were washed with
PBS and fixed in PBS containing 3.7% formaldehyde for 10 min. The
cells were washed in PBS, and stained in PBS containing 5 µg/ml
Hoechst 33342 for 15 min at ambient temperature. The monolayer were
washed three times with PBS and observed by fluorescence microscopy
(fluorescein isothiocyanate filter set). Images were captured on Kodak
Royal Gold 200 film and scanned into a Macintosh G4 computer using an
Agfa T1200 scanner.
80 °C using Kodak Lightning Plus screens.
Scanned arrays were analyzed using Atlas Image software
(CLONTECH), comparing relative intensities of
specific cDNA "spots," which were corrected for differences in
the relative intensities of housekeeping genes between membranes prior
to analysis. Three separate Array analyses were performed with probes
generated from RNA resulting from two different experiments. Results
for cDNAs depicted below are the mean of these three separate
determinations. Data is presented as mRNA content in
KCREB-expressing cells relative to mRNA content in LacZ-expressing cells.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

View larger version (28K):
[in a new window]
Fig. 1.
Inducible expression of KCREB in 3T3-L1
adipocytes inhibits CRE-mediated transcription and elicits fat cell
loss. 3T3-L1 pre-adipocytes were transfected with an
Ecdysone-inducible KCREB expression system as described under
"Experimental Procedures." The cells were then propagated to
confluence, and adipogenesis was induced with Bt2cAMP,
insulin, and dexamethasone. A, inducible expression of KCREB
protein was verified by preparing nuclear extracts from mature
adipocytes (day 10 in post-induction) treated with 1.0 µM
Ponasterone A (Pon. A) for 24 h or untreated, control
cells. 25 µg of extract protein from each extract was resolved on
10% polyacrylamide-SDS gels and transferred to nitrocellulose. After
the blots were blocked, they were incubated with antibody to total
CREB, which recognizes both CREB and KCREB. The panel shows
a representative Western blot of induced KCREB expression.
B, mature adipocytes, stably transfected with the inducible
KCREB expression system, were transfected with a plasmid containing the
CRE-containing somatostatin gene promoter linked to a
luciferase reporter gene using Superfect reagent. As indicated, KCREB
expression was induced with 10 µM Ponasterone A
(KCREB + lanes) overnight. The following day, the cells were
treated with 0.3 mM Bt2cAMP for 4 h as
indicated. Luciferase expression was measured in lysates as an index of
transcriptional activity, and levels are shown relative to luciferase
activity in cells not treated with Ponasterone A or
Bt2cAMP. Levels were corrected for transfection efficiency
by co-transfecting cells with a plasmid containing the Rous sarcoma
virus (RSV) long terminal repeat linked to a
-galactosidase
reporter. The data shown are averaged from three separate assays.
C, mature adipocytes were treated with 10 µM
Ponasterone A on day 0 to induce KCREB expression. The cells were refed
every 3 days with complete medium containing 10 µM
Ponasterone A for 9 days. Duplicate wells of cells were stained with
Oil Red O and counterstained with hematoxylin on days 0 and 9. The
panels show representative photomicrographs of cells on days
0 and 9 of treatment.

View larger version (68K):
[in a new window]
Fig. 2.
KCREB expression induces adipocyte apoptosis
as determined by Hoechst staining and changes in membrane
structure. 3T3-L1 pre-adipocytes were stably transfected with the
Ecdysone-inducible KCREB expression system as described under
"Experimental Procedures." The cells were treated with a mixture of
insulin, dexamethasone, and Bt2cAMP to induce
adipogenesis and cultured for 10 days until greater then 90% of the
cells contained lipid vesicles. A, mature adipocytes were
treated with 10 µM Ponasterone A to induce KCREB
expression. On days 0 through 5, duplicate wells of cells were fixed in
10% formaldehyde in phosphate-buffered saline (PBS) for 10 min and
stained with Oil Red O. Cells were subsequently stained with Hoechst
33342 for 15 min and rinsed three times with PBS. Representative
fluorescence photomicrographs are shown of cells fixed and stained each
day and visualized with a fluorescein isothiocyanate filter set.
B, representative fluorescence photomicrograph (not Oil Red
O-stained) of cells treated with 10 µM Ponasterone A for
24 h. A cell with normal (Norm.) nucleus and
conventional adipocyte morphology is present at the top of the
panel. Two cells with bright yellow, condensed
nuclei and retracted, spindle-shaped
morphology are present at the bottom. C,
representative photomicrograph, taken with phase optics, showing the
presence of membrane blebs on a cell treated with 10 µM
Ponasterone A for 48 h.
Another hallmark of apoptotic cell death is DNA fragmentation. This
parameter was measured by subjecting KCREB-expressing adipocytes to
flow cytometric analysis after staining with propidium iodide.
Apoptotic cells are evident on the resulting histograms as a
"sub-G0/G1" peak indicative of DNA
fragmentation and reduced DNA content. The number of cells in the
sub-G0/G1 peak increased from day 0 through day
3 and then declined (Fig. 3); consistent with the temporal changes in nuclear condensation shown in Fig. 2A. We also noted an increase in the number of cells in the
S and G2/M regions of the histograms on days 4-6. No lipid
vesicles were evident during microscopic examination of cells in the S and G2/M regions (data not shown). Given the uniform
expression of KCREB in the cell population (18), we speculate that
these cells represent undifferentiated cells that survive KCREB
expression and proliferate during and after the death of mature
adipocytes. It is also possible that these cells express little of no
KCREB upon exposure to Ponasterone A and, therefore, do not undergo apoptotic cell death. The specific nature of these cells is
currently being investigated in our laboratory.
|
Given CREB's primary function in regulating gene expression, we
examined the levels of expression of several apoptotic genes in
untreated adipocytes, or adipocytes inducibly expressing KCREB for
24 h. For these assays, mouse Atlas 1.2 gene arrays
(CLONTECH) were employed. We found that the
expression of several pro-apoptotic genes were elevated in
KCREB-expressing cells, most notably Receptor Interacting
Protein (RIP), and Interleukin 1
Converting
Enzyme (ICE, or caspase-1) (Fig.
4A). At the same time,
expression of the anti-apoptotic signaling enzyme, protein kinase B/Akt
(Fig. 4, Akt) was dramatically diminished by KCREB.
Down-regulation of Akt and up-regulation of RIP and ICE by KCREB in
adipocytes was confirmed by Western blot analysis (Fig. 4B).
The Atlas gene arrays contain several other apoptosis-related genes,
including caspases 2, 7, and 11,
bcl-2, and BAX. However, either no change in the expression of these genes was observed, or no detectable signal
was present on the autoradiograms even after prolonged exposure.
Although a number of factors participate in apoptotic cell death, we
have examined the contribution of Akt to adipocyte survival in
preliminary experiments. We have found that ectopic expression of
dominant negative Akt (Akt(K179M)) or treatment of cells with the PI3K
inhibitor, LY294002, resulted in apoptosis of adipocytes as determined
by FACS analysis (Fig. 5). The percentage of apoptotic cells with either of these two treatments reached ~30%
to 50% within 48 h, whereas no apoptotic cells were detected in
populations expressing an LacZ protein. These preliminary data suggest
that one mechanism by which inhibition of CREB induces apoptosis is
through decreased Akt signaling.
|
|
The ability of KCREB to induce adipocyte apoptosis suggested that
constitutively active forms of CREB might block programmed cell death.
To test this concept, the Ecdysone-inducible expression system was
employed to express the active CREB mutant, CREB-DIEDML, which
stimulates transcription and associates with the transcriptional co-adaptor, CREB-binding protein (CBP) p300, in a
phosphorylation-independent manner (28). First, we verified that the
protein was expressed in response to Ponasterone A treatment by Western
blot analysis (Fig. 6A).
Simultaneously, we assessed the ability of CREB-DIEDML expression to
drive transcription (luciferase production) from the CRE-containing,
somatostatin gene promoter. We found that low doses of
Ponasterone A (0.1 µM) and low levels of CREB-DIEDML elicited a 6.8-fold increase in transcription, whereas transcription levels decreased with further increases in Ponasterone A/CREB-DIEDML (Fig. 6B). The decrease in transcription levels with high
CREB-DIEDML expression probably reflects transcriptional squelching due
to excess transactivator levels. Having optimized CREB-DIEDML
expression/activity, we tested the ability of this factor to block
adipocyte apoptosis induced by TNF-
. As shown in Fig. 6C,
TNF-
produced a substantial increase in the number of control cells
(ectopically expressing LacZ) with condensed nuclei as determined by
Hoechst staining. However, in cells expressing CREB-DIEDML, fewer
condensed nuclei were evident. These cell populations were subjected to
FACS analysis to quantitate the number of apoptotic cells. No apoptotic
nuclei were evident in untreated control cells (Fig. 6D).
The percentage of apoptotic cells in the LacZ-expressing,
TNF-
-treated populations averaged 30%, whereas the percentage for
CREB-DIEDML-expressing, TNF-
-treated cells averaged only 5%.
|
| |
DISCUSSION |
|---|
|
|
|---|
In this paper we have shown that decreases in CREB activity
generated by inducible, ectopic expression of KCREB and other dominant
negative "CREBs" stimulate apoptosis of mature 3T3-L1 adipocytes in
culture. Apoptosis was confirmed by chromatin condensation (Hoechst
staining), changes in membrane morphology (retraction and blebbing),
and cellular DNA degradation (subdiploid or
sub-G0/G1 cells in FACS analysis). The ability
of KCREB to induce adipocyte apoptosis appears to be due, in part, to
the increased expression of certain pro-apoptotic genes, including
RIP and ICE, and the decreased expression of the anti-apoptotic
signaling enzyme, Akt. Although changes in the expression of most of
these factors await confirmation, the decreased expression of Akt in
response to KCREB was also noted by Western blot analysis. Finally, we
demonstrated that ectopic expression of constitutively active forms of
CREB partially inhibits the induction of adipocyte apoptosis in
response to TNF-
exposure.
Other groups have shown that insulin and IGF-1 inhibit apoptosis of
adipocytes and pre-adipocytes in response to TNF-
or serum
deprivation (17, 29, 30). We have shown that these hormones stimulate
CREB phosphorylation and transcriptional activity in several cell
types, including 3T3-L1 pre-adipocytes and adipocytes through the
activation of ERK and PI3K signaling systems and through the inhibition
of protein phosphatase 2A (24, 25, 31, 32). Our current data implicate
CREB as an important nuclear effector of the protective effects of
insulin and IGF-1.
The ability of KCREB to initiate programmed cell death in adipocytes is consistent with the role of CREB in survival/apoptosis of other cells types, its regulation of survival/apoptotic genes, and its regulation by survival-associated growth factors. This is especially true of neurons. Walton et al. (33) have shown that CREB overexpression and prolonged phosphorylation protects neurons from okadaic acid-induced apoptosis, and Ginty and colleagues (26) have shown that nerve growth factor and other neurotrophins promote neuronal survival in part through CREB activation of bcl-2 expression and other pro-survival genes. Similarly, Pugazhenthi et al. (24, 25) have shown that IGF-1 prevents apoptosis of PC12 cells in culture by activating CREB, which in turn increases bcl-2 expression. Interestingly, CREB levels were reduced by caspase-mediated cleavage in neuroblastoma cells undergoing apoptosis in response to staurosporine, suggesting that apoptosis is associated with a decrease in CREB that normally protects against programmed cell death (23). Finally, addition of extracellular HIV-1 Tat protein to PC12 cells elicits a chronic down-regulation of CREB content and phosphorylation, and a progressive increase in apoptosis (34). This may account, partly, for the neuronal apoptosis and subsequent dementia frequently observed in HIV-infected individuals.
CREB and proteins of the related activating transcription factor (ATF), cAMP-response element repressor/inducible cAMP-early repressor family of proteins also regulate survival of other cell types. For example, ectopic expression of KCREB in human melanoma cells decreases their resistance to radiation and renders them susceptible to thapsigargin-induced apoptosis, suggesting that CREB and the related ATF1 transcription factor may contribute to the acquisition of the malignant phenotype (35). Walker and colleagues (36) have shown that introduction of the phosphorylation-deficient, dominant negative CREBm1 into seminiferous tubules disrupts spermatogenesis through the apoptosis of spermatocyte germ cells. These data indicate that CREB and related proteins play key roles in the survival and development of numerous cell types and tissues.
An interesting observation in this study was the down-regulation of Akt/protein kinase B expression in KCREB-expressing adipocytes. Of the several apoptosis-related genes regulated by KCREB in our gene array analysis, we were able to confirm the regulation of Akt expression by Western blot analysis. The Akt serine/threonine-specific kinases are key mediators of cell survival in response to growth factors and calcium influx (37). Phosphorylation by Akt represses the activity of several pro-apoptotic molecules, including caspase-9, BAD, Forkhead transcription factors, and GSK-3 (38-41). Gagnon et al. (30) have shown that IGF-1 inhibits apoptosis of 3T3-L1 pre-adipocytes following serum deprivation via the activation of PI3K/Akt signaling. This pathway also contributes to adipogenesis in 3T3-L1 cells, with agents that block this signaling system inhibiting the conversion of pre-adipocytes to adipocytes (42-44). Interestingly, we have noted elevated Akt expression in gene array experiments and by Western blot, in 3T3-L1 pre-adipocytes treated with conventional differentiation-inducing agents, or inducibly expressing the constitutively active VP16-CREB or CREB-DIEDML.2 We have extended these results to bovine aortic smooth muscle cells in culture, wherein KCREB decreases Akt expression and induces apoptosis, but CREB-DIEDML increases Akt expression.2 Although these data are far from confirmatory, it is tempting to speculate that many of CREBs functions may be mediated via the direct regulation of Akt gene expression.
We have previously demonstrated that VP16-CREB and CREB-DIEDML induce
adipogenesis in 3T3-L1 pre-adipocytes, and here we show that dominant
negative KCREB stimulates adipocyte apoptosis while constitutively
active CREBs protect against cell death in response to TNF-
. The
development of new fat cells, and the death of mature adipocytes
probably play competing roles in controlling adipose tissue mass and,
in turn, in regulating insulin sensitivity. This connection is
frequently manifest in obese individuals who develop insulin
resistance, and ultimately type II diabetes, apparently due to the
overabundance of stored fat in existing adipocytes (1). In most cases,
agents that stimulate the development of new fat cells and the
redistribution of fat stores vastly improves overall insulin
sensitivity (45). At the other extreme, congenital and acquired
lipoatrophic and lipodystrophic disorders are also commonly associated
with increased insulin resistance (46, 47). The conditions reflect a
loss or decreased number of fat cells that leads to insulin resistance.
The participation of CREB in the generation of new fat cells and its
ability to block adipocyte apoptosis suggest that CREB may be a central
determinant of overall insulin sensitivity. Experiments to explore the
ability of constitutively active and dominant negative CREBs to
modulate adipose tissue mass and insulin responsiveness are currently
underway in our laboratories.
Our data indicate that CREB plays a central role in adipocyte survival,
perhaps by regulating the expression of anti-apoptotic genes such as
Akt. Our results not only extend the role of CREB in adipocyte biology
but also highlight the general developmental and survival role of this
factor in numerous cell and tissue types.
| |
FOOTNOTES |
|---|
* This work was supported by Veterans Affairs MERIT reviews (to J. E. B. R.) and REAP funding (to J. E. B. R.), by National Institutes of Health Grants RO1-DK53969 (to D. J. K.) and K08-DK02351 (to J. E. B. R.), and by an ADA research award (to J. E. B. R.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
§§ To whom correspondence should be addressed: Pulmonary and Critical Care Section, Veterans Affairs Medical Center, 1055 Clermont St., Denver, CO 80220. Tel.: 303-399-8020 (Ext. 2778); Fax: 303-393-4639; E-mail: Dwight.Klemm@UCHSC.edu.
Published, JBC Papers in Press, November 1, 2001, DOI 10.1074/jbc.M107923200
2 J. E. B. Reusch and D. J. Klemm, unpublished data.
| |
ABBREVIATIONS |
|---|
The abbreviations used are:
TNF-
, tumor
necrosis factor-
;
HIV, human immunodeficiency virus;
MAPK, mitogen-activated protein kinase;
CRE, cAMP-response element;
CREB, cAMP-response element-binding protein;
KCREB, dominant negative form of
CREB;
CREB- Bt2cAMP, dibutyryl cyclic AMP;
PI3K, phosphatidylinositol 3-kinase;
FCS, fetal calf serum;
PBS, phosphate-buffered saline;
RIP, receptor interacting protein;
ICE, interleukin 1
converting enzyme;
FACS, fluorescence-activated cell
sorting;
IGF-1, insulin-like growth factor 1;
ERK, extracellular
signal-regulated kinase;
ATF, activating transcription factor.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Spiegelman, B. M., and Flier, J. S. (1996) Cell 87, 377-389 |
| 2. | U. S. Department of Health and Human Services. (1998) National Health and Nutrition Survey, Vol. III, 1988-1994 , Vol. 1996 , Centers for Disease Control and Prevention, National Center for Health Statistics, Washington, D. C. |
| 3. | McIntyre, A. M. (1998) J. R. Soc. Health 118, 76-84 |
| 4. | Pi-Sunyer, F.-X., Laferrere, B., Aronne, L. J., and Bray, G. A. (1999) J. Clin. Endocrinol. Metab. 84, 3-7 |
| 5. | Domingo, P., Matias-Guiu, X., Pujol, R. M., Francia, E., Lagarda, E., Sambeat, M. A., and Vazquez, G. (1999) AIDS 13, 2261-2267 |
| 6. | Murao, S., Hirata, K., Ishida, T., and Takahara, J. (1998) Intern. Med. 37, 1031-1033 |
| 7. | Lenhard, J. M., Furfine, E. S., Jain, R. G., Ittoop, O., Orband-Miller, L. A., Blanchard, S. G., Paulik, M. A., and Weiel, J. E. (2000) Antiviral Res. 47, 121-129 |
| 8. | Dowell, P., Flexner, C., Kwiterovich, P. O., and Lane, M. D. (2000) J. Biol. Chem. 275, 41325-41332 |
| 9. | Hirsch, J., and Han, P. W. (1969) J. Lipid Res. 10, 77-82 |
| 10. | Roncari, D. A. K., Lau, D. C. W., and Kindler, S. (1981) Metabolism 30, 425-427 |
| 11. | Engleman, J. A., Lisanti, M. P., and Scherer, P. E. (1998) J. Biol. Chem. 273, 32111-32120 |
| 12. | Prins, J. B., Walker, N. I., Winterford, C. M., and Cameron, D. P. (1994) Biochem. Biophys. Res. Commun. 201, 500-507 |
| 13. | Prins, J. B., Walker, N. I., Winterford, C. M., and Cameron, D. P. (1994) Biochem. Biophys. Res. Commun. 205, 625-630 |
| 14. | Prins, J. B., and O'Rahilly, S. (1997) Clin. Sci. 93, 3-11 |
| 15. | Prins, J. B., Niesler, C. U., Winterford, C. M., Bright, N. A., Siddle, K., O'Rahilly, S., Walker, N. I., and Cameron, D. P. (1997) Diabetes 46, 1939-1944 |
| 16. | Qian, H., Azain, M. J., Compton, M. M., Hartzell, D. L., Hausman, G. J., and Baile, C. A. (1998) Endocrinology 139, 791-794 |
| 17. | Qian, H., Hausman, D. B., Compton, M. M., Martin, R. J., Della-Fera, M. A., Heartzell, D. L., and Baile, C. A. (2001) Biochem. Biophys. Res. Commun. 284, 1176-1183 |
| 18. | Reusch, J. E.-B., Colton, L. A., and Klemm, D. J. (2000) Mol. Cell. Biol. 20, 1008-1020 |
| 19. | Klemm, D. J., Leitner, J. W., Watson, P., Nesterova, A., Reusch, J. E. B., Goalstone, M. L., and Draznin, B. (2001) J. Biol. Chem. 276, 28430-28435 |
| 20. | Sung, J. Y., Shin, S. W., Ahn, Y. S., and Chung, K. C. (2001) J. Biol. Chem. 276, 13858-13866 |
| 21. | Shimomura, A., Okamoto, Y., Hirata, Y., Kobayashi, M., Kawakami, K., Kiuchi, K., Wakabayashi, T., and Hagiwara, M. (1998) J. Neurochem. 70, 1029-1034 |
| 22. | Heasley, L. E., Benedict, S., Gleavy, J., and Johnson, G. L. (1991) Cell Regul. 2, 479-489 |
| 23. | Francois, F., Godhinho, M. J., and Grimes, M. L. (2000) FEBS Lett. 486, 281-284 |
| 24. | Pugazhenthi, S., Miller, E., Sable, C., Young, P. R., Heidenreich, K. A., Boxer, L. M., and Reusch, J. E. B. (1999) J. Biol. Chem. 274, 27529-27535 |
| 25. | Pugazhenthi, S., Nesterova, A., Sable, C., Heidenreich, K. A., Boxer, L. M., Heasley, L. E., and Reusch, J. E. B. (2000) J. Biol. Chem. 275, 10761-10766 |
| 26. | Riccio, A., Ahn, S., Davenport, C. M., Blendy, J. A., and Ginty, D. D. (1999) Science 286, 2358-2361 |
| 27. | Walton, K. M., Rehfuss, R. P., Chrivia, J. C., Lochner, J. E., and Goodman, R. H. (1992) Mol. Endocrinol. 6, 647-655 |
| 28. | Cardinaux, J. R., Notis, J. C., Zhang, Q., Vo, N., Craig, J. C., Fass, D. M., Brennan, R. G., and Goodman, R. H. (2000) Mol. Cell. Biol. 20, 1546-1552 |
| 29. | Urso, B., Niesler, C. U., O'Rahilly, S., and Siddle, K. (2001) Cell. Signalling 13, 279-285 |
| 30. | Gagnon, A. M., Dods, P., Roustan-Delatour, N., Chen, C. S., and Sorisky, A. (2001) Endocrinology 142, 205-212 |
| 31. | Klemm, D. J., Roesler, W. J., Boras, T., Colton, L. A., Felder, K., and Reusch, J. E.-B. (1998) J. Biol. Chem. 273, 917-923 |
| 32. | Reusch, J. E.-B., Hsieh, P., Klemm, D., Hoeffler, J., and Draznin, B. (1994) Endocrinology 135, 2418-2422 |
| 33. | Walton, M., Woodgate, A. M., Muravlev, A., Xu, R., During, M. J., and Dragunow, M. (1999) J. Neurochem. 73, 1836-1842 |
| 34. | Zauli, G., Milani, D., Mirandola, P., Mazzoni, M., Secchiero, P., Miscia, S., and Capitani, S. (2001) FASEB J. 15, 483-491 |
| 35. | Jean, D., Harbison, M., McConkey, D. J., Ronai, Z., and Bar-Eli, M. (1998) J. Biol. Chem. 273, 24884-24890 |
| 36. | Scobey, M., Bertera, S., Someras, J., Watkins, S., Zeleznik, A., and Walker, W. (2001) Endocrinology 142, 948-954 |
| 37. | Franke, T. F., Kaplan, D. R., and Cantley, L. C. (1997) Cell 88, 435-437 |
| 38. | Brunet, A., Bonni, A., Zigmond, M. J., Lin, M. Z., Juo, P., Hu, L. S., Anderson, M. J., Arden, K. C., Blenis, J., and Greenberg, M. E. (1999) Cell 96, 857-868 |
| 39. | Cardone, M. H., Roy, N., Stennicke, H. R., Salveson, G. S., Franke, T. F., Stanbridge, E., Frisch, S., and Reed, J. C. (1998) Science 282, 1318-1321 |
| 40. | Datta, S. R., Dudek, H., Tao, X., Masters, S., Fu, H., Gotoh, Y., and Greenberg, M. E. (1997) Cell 91, 231-241 |
| 41. | Pap, M., and Cooper, G. M. (1998) J. Biol. Chem. 273, 19929-19932 |
| 42. | Xia, X., and Serrero, G. (1999) J. Cell Physiol. 178, 9-16 |
| 43. | Sakaue, H., Ogawa, W., Matsumoto, M., Kuroda, S., Takata, M., Sugimoto, T., Spiegelman, B. M., and Kasuga, M. (1998) J. Biol. Chem. 273, 28945-28952 |
| 44. | Gagnon, A. M., Chen, C. S., and Sorisky, A. (1999) Diabetes 48, 691-698 |
| 45. | Kletzien, R. F., Clarke, S. D., and Ulrich, R. G. (1992) Mol. Pharmacol. 41, 393-398 |
| 46. | Ganda, O. P. (2000) Ann. Intern. Med. 133, 304-306 |
| 47. | Hegele, R. A. (2000) Curr. Atheroscler. Rep. 2, 397-404 |
This article has been cited by other articles:
![]() |
E. Szabo, Y. Qiu, S. Baksh, M. Michalak, and M. Opas Calreticulin inhibits commitment to adipocyte differentiation J. Cell Biol., October 23, 2008; 182(1): 103 - 116. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. K. Petersen, L. Madsen, L. M. Pedersen, P. Hallenborg, H. Hagland, K. Viste, S. O. Doskeland, and K. Kristiansen Cyclic AMP (cAMP)-Mediated Stimulation of Adipocyte Differentiation Requires the Synergistic Action of Epac- and cAMP-Dependent Protein Kinase-Dependent Processes Mol. Cell. Biol., June 1, 2008; 28(11): 3804 - 3816. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. Dworet and J. L. Meinkoth Interference with 3',5'-Cyclic Adenosine Monophosphate Response Element Binding Protein Stimulates Apoptosis through Aberrant Cell Cycle Progression and Checkpoint Activation Mol. Endocrinol., May 1, 2006; 20(5): 1112 - 1120. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Vankoningsloo, A. De Pauw, A. Houbion, S. Tejerina, C. Demazy, F. de Longueville, V. Bertholet, P. Renard, J. Remacle, P. Holvoet, et al. CREB activation induced by mitochondrial dysfunction triggers triglyceride accumulation in 3T3-L1 preadipocytes J. Cell Sci., April 1, 2006; 119(7): 1266 - 1282. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Ichiki Role of cAMP Response Element Binding Protein in Cardiovascular Remodeling: Good, Bad, or Both? Arterioscler. Thromb. Vasc. Biol., March 1, 2006; 26(3): 449 - 455. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. K. Misra and S. V. Pizzo Coordinate Regulation of Forskolin-induced Cellular Proliferation in Macrophages by Protein Kinase A/cAMP-response Element-binding Protein (CREB) and Epac1-Rap1 Signaling: EFFECTS OF SILENCING CREB GENE EXPRESSION ON Akt ACTIVATION J. Biol. Chem., November 18, 2005; 280(46): 38276 - 38289. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Vankoningsloo, M. Piens, C. Lecocq, A. Gilson, A. De Pauw, P. Renard, C. Demazy, A. Houbion, M. Raes, and T. Arnould Mitochondrial dysfunction induces triglyceride accumulation in 3T3-L1 cells: role of fatty acid {beta}-oxidation and glucose J. Lipid Res., June 1, 2005; 46(6): 1133 - 1149. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Fischer-Posovszky, H. Tornqvist, K.-M. Debatin, and M. Wabitsch Inhibition of Death-Receptor Mediated Apoptosis in Human Adipocytes by the Insulin-Like Growth Factor I (IGF-I)/IGF-I Receptor Autocrine Circuit Endocrinology, April 1, 2004; 145(4): 1849 - 1859. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Shanmugam, I. T. Gaw Gonzalo, and R. Natarajan Molecular Mechanisms of High Glucose-Induced Cyclooxygenase-2 Expression in Monocytes Diabetes, March 1, 2004; 53(3): 795 - 802. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-H. Yu and H. Zhu Chronological changes in metabolism and functions of cultured adipocytes: a hypothesis for cell aging in mature adipocytes Am J Physiol Endocrinol Metab, March 1, 2004; 286(3): E402 - E410. [Abstract] [Full Text] |
||||
![]() |
J. E.B. Reusch and D. J. Klemm Cyclic AMP Response Element-Binding Protein in the Vessel Wall: Good or Bad? Circulation, September 9, 2003; 108(10): 1164 - 1166. [Full Text] [PDF] |
||||
![]() |
T. Tokunou, R. Shibata, H. Kai, T. Ichiki, T. Morisaki, K. Fukuyama, H. Ono, N. Iino, S. Masuda, H. Shimokawa, et al. Apoptosis Induced by Inhibition of Cyclic AMP Response Element-Binding Protein in Vascular Smooth Muscle Cells Circulation, September 9, 2003; 108(10): 1246 - 1252. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Rosenberg, L. Groussin, E. Jullian, K. Perlemoine, S. Medjane, A. Louvel, X. Bertagna, and J. Bertherat Transcription Factor 3',5'-Cyclic Adenosine 5'-Monophosphate-Responsive Element-Binding Protein (CREB) Is Decreased during Human Adrenal Cortex Tumorigenesis and Fetal Development J. Clin. Endocrinol. Metab., August 1, 2003; 88(8): 3958 - 3965. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Horike, H. Takemori, Y. Katoh, J. Doi, L. Min, T. Asan |